in principle, the national drug list is adjusted every two years, and the drug lists of all provinces, autonomous regions and municipalities directly under the central government are adjusted accordingly. The work of supplementing new drugs in the National Drug List is carried out once a year, and all localities are not allowed to supplement new drugs by themselves. All provinces, autonomous regions and municipalities directly under the central government may, according to the actual situation, determine whether to enter the local B-list of drugs added to the national B-list.
(2) changes of disease spectrum in China;
(3) monitoring and evaluation of adverse drug reactions;
(4) monitoring and evaluating the application of national essential drugs; 5) Evidence-based medicine and pharmacoeconomic evaluation of listed drugs;
(6) Other circumstances as stipulated by the State Committee on Essential Drugs.
: In principle, the National Drug List is adjusted every two years, and the Drug Lists of all provinces, autonomous regions and municipalities directly under the Central Government are adjusted accordingly. The work of supplementing new drugs in the National Drug List is carried out once a year, and all localities are not allowed to supplement new drugs by themselves. For drugs added to the national Category B list, all provinces, autonomous regions and municipalities directly under the Central Government
2. According to the actual situation, it can be determined whether to enter the local Category B list.
in the process of formulating the drug list, the administrative departments of labor and social security at all levels will no longer carry out drug inspection, and will not charge the drug production and distribution enterprises evaluation fees and various fees, and will not make excuses to increase the burden on enterprises. The funds required for the formulation of the Drug List shall be applied by the administrative department of labor security to the financial department, and shall be solved by the financial allocation at the same level.
article 4
the selection of national essential drugs should be based on the principles of prevention and control necessity, safety and effectiveness, reasonable price, convenient use, equal emphasis on Chinese and western medicines, basic guarantee, first choice in clinical practice, and availability at the grass-roots level, and the varieties (dosage forms) and quantities should be reasonably determined in combination with the characteristics of drug use in China and with reference to international experience.
the formulation of the national list of essential drugs should be linked with the basic public health service system, basic medical service system and basic medical security system.
article 5
the chemicals, biological products and Chinese patent medicines listed in the national list of essential drugs shall be those listed in the pharmacopoeia of the people's Republic of China and whose drug standards have been published by the state food and drug supervision department and the former Ministry of health. In addition to first-aid and rescue drugs, the inclusion of exclusive production varieties in the national list of essential drugs should be independently demonstrated.
The names of chemicals and biological products use the chemical components expressed in Chinese common names and English international generic drug names, and the dosage forms are listed separately; Chinese patent medicine adopts the generic name of drug.